Anti-CSF1R/M-CSFR/CD115 Antibody (Cabiralizumab)
Catalog No.
F2065
Anti-CSF1R/M-CSFR/CD115 Antibody (Cabiralizumab)
Featured Products
Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and anti-tumor T cell immune responses. Cabiralizumab inhibits osteoclast activation and prevents bone destruction, and can be used in rheumatoid arthritis (RA) research.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1613144-80-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
FPA-008, BMS-986227, ONO-4687
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P07333
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CSF1R / M CSFR, Fc Tag at 2 ug/mL can bind Anti-CSF1R/M-CSFR/CD115 Antibody (Cabiralizumab)
CSF1R / M-CSFR / CD115
Please avoid freeze-thaw cycles.